Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
25 Cards in this Set
- Front
- Back
What is the prototypical example of a member of the opiod analgesic class?
What type of pain does this drug control? |
morphine
moderate/severe pain |
|
What are other uses for morphine?
|
- cough suppression
- anesthesia - decrease GI motility - adjunct for pulmonary edema - drugs of abuse |
|
What are examples of endogenous opiods that are released during stress?
|
- endorphins
- enkephalins - dynorphins |
|
What is the opiod mechanism?
Name the three different types of receptors/ |
binds to the opiod receptors in the CNS
-Mu -Kappa -Delta |
|
What is the difference between the mu, kappa, and delta opiod receptors?
|
- mu -- strongest analgesic with the most severe side effects (respiratory depression, constipation, dependence)
- Kappa -- analgesic, less side effects, sedation, psychotic effects - Delta -- analgesic, increases hormone release |
|
What is an example of a mixed opioid receptor?
|
agonist Kappa and antagonist mu providing less chance of fatality due to respiratory depression
|
|
Opioid bind to _________ receptors.
|
opioid G-protein coupled receptors to inhibit afferent pain transmission in ascending pain pathways
|
|
What is opioid's effect on the pain-pathway presynaptic synapses?
|
G proteins inhibit calcium entry and cAMP release which causes less NT release (calcium required for NT release)
|
|
What is opioid's effect on the pain-pathway post-synaptic synapses?
|
G proteins open K+ channels (lose K+) and hyperpolarize the membrane making it harder to excite the neuron
|
|
How does the opioid activate the descending pain control pathways via disinhibition? First, define disinhibition.
|
Disinhibition -- normal act is to inhibit, something stops this disinhibition and allows the pathway to occur resulting in less pain sensation
|
|
How are opioids administered?
|
some are oral and some are parenteral (IV, epidural, intrathecal, transdermal)
|
|
Where are the opioids metabolized (inactivated)?
|
in the LIVER
|
|
What is the important of weaning from a strong mu?
|
there is a high risk of dependence so we try to get patient off morphine IV ASAP and move to orals
|
|
Give an example of a strong opioid agonist.
|
mu agonist (MORPHINE)
|
|
Give an example of a mild-to-moderate opioid agonist.
|
codeine (generic), used for moderate pain, stimulates each of the opioid receptors (lower affinity and efficacy)
|
|
Give an example of a mixed agonist-antagonist opioid.
|
stimulate kappa or delta but blocks or only partially stimulates mu
- used for recovery from dependence so mu isn't stimulated - blocks mu from causing a functional change |
|
What is an opioid antagonist?
|
binds to an opioid receptor without having a functional effect (no effect on respiration)
|
|
What are some adverse affects of opioids as a class?
|
sedation, euphoria, respiratory depression (mu receptor), CV problems (OH), GI distress/constipation (comorbidity for SCI patients)
|
|
Define addiction as it relates to opioids.
|
compulsive drug use, psychological dependence
|
|
Define tolerance as it relates to opioids.
|
increase of a drug dose to have the same functional effect
|
|
Define physical dependence as it relates to opioids.
|
onset of withdrawal symptoms if the drug is suddenly stopped
|
|
What are opioid withdrawal symptoms?
|
- flu-like symptoms
- insomnia - irritability - tachycardia - uncontrollable yawning - muscle aches (PT intervention to treat these) |
|
What are 3 problems with opioid drug use?
|
1. addiction
2. tolerance 3. physical dependance |
|
What is pharmacological treatment for opioid addiction?
|
1. use methadone -- strong opioid agonist, has milder withdrawal symptoms than other opioids, used instead of the drug of abuse
2. buprenophine/buprenex -- mixed agonist-antagonist, partially activates mu receptors, stronger agonist for K receptors (some pain control but without the effects of K) |
|
What is enzyme induction?
|
an increased ability to breakdown drug
|